Navigation Links
NW Bio Provides Guidance On Phase III Trial Enrollment Timing: Completion Expected To Be Faster Or More Efficient Than Relevant Comparison Trials
Date:3/7/2013

li>Agenus, Inc. (NASDAQ: AGEN) is conducting a Phase II trial with 55 patients, which began recruiting in Q2, 2009 and stopped recruiting in Q2, 2012.

NW Bio has primarily been enrolling its Phase III trial since Q2 of 2011.  The Company undertook a limited period of enrollment in 2008, and then kept the trial going with the patients already enrolled, but suspended new enrollment due to resource constraints during the worst of the economic downturn, through the end of 2010.  The Company began the process of reactivating clinical trial sites for new enrollment in Q1 2011, and resumed screening in Q2 of 2011.

NW Bio expects to complete enrollment in its phase III trial by Q1 or early Q2 of next year – an overall enrollment period of 14 or 15 calendar quarters, including both the 2008 period and the period since Q2 2011. 

This represents a rate of enrollment that compares as follows with Celldex, IMUC and Agenus: Total Trial

 Enrollment

Enrollment

Period

Pace of Enrollment to

Completion, Based On

Enrollment Period 

NW Bio

Ph. III

 

312 patients

14 quarters or

15 quarters

22.3 patients per quarter or

20.8 patients per quarter 

IMUC

Ph. II

 

124 patients

7 quarters

17.7 patients per quarterCelldex

Ph. III

440 patients

≥16 quarters [est.]

 

27.5 patients per quarter*

 

*[164 clinical trial sites worldwide]

  

Agenus

Ph. II

 

55 patients

12 quarters

4.6 patients per quarterNotably, even if the completion of NW Bio's Phase III trial enrollment were to take substantially longer than the Company's projection of Q1 or early Q2 20
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Medical Alarm Concepts Provides Investor Update - Signs Deal with Health Care Insurance Provider for Medical Alarms
2. Arena Pharmaceuticals Provides Corporate Update and Reviews Fourth Quarter and Full Year 2012 Financial Results
3. Compass Diversified Holdings Provides Shareholders with 2012 Tax Information
4. Volcano Corporation Provides Additional Guidance For 2013
5. Lexicon Pharmaceuticals Provides Clinical Pipeline Update And Reports 2012 Fourth Quarter And Full Year Financial Results
6. AcelRx Pharmaceuticals Provides Clinical Trial Updates
7. Masimo Reports Fourth Quarter and Full Year 2012 Financial Results; Provides 2013 Financial Guidance
8. US Peptides Provides New Article Discussing HGH and Athletic Performance
9. BioMed Realty Trust Provides Notice of Redemption of 7.375% Series A Cumulative Redeemable Preferred Stock
10. Genomic Health Announces Year-End 2012 Financial Results, Provides 2013 Financial Outlook
11. Breakthrough Procedure Provides Relief for Acid Reflux
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... June 19, 2013 Today MedeAnalytics, a ... the next-generation of its Employer Group and ... plans to provide their employer groups an intuitive ... medical and prescription drug claims, network utilization, and ... http://photos.prnewswire.com/prnh/20100621/SF23660LOGO ) "Employer Group and ...
(Date:6/18/2013)... -- , Safinamide significantly improves responder ... add-on to levodopa Safinamide is associated ... fluctuating PD patients as add-on to levodopa ... a research and development company focused on novel ... S.p.A., a pharmaceutical company strongly committed to the ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
Breaking Medicine Technology:MedeAnalytics Introduces Next-Generation Employer Group and Individual Business Analytics Solution 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 2Safinamide Phase III Study Results Presented at 2013 MDS Meeting 3Safinamide Phase III Study Results Presented at 2013 MDS Meeting 4Safinamide Phase III Study Results Presented at 2013 MDS Meeting 5Safinamide Phase III Study Results Presented at 2013 MDS Meeting 6Three-in-One X3130 Appliance Inlet Module 2
... 2011 First Advantage , a ... solutions, today announced that it has made a significant ... The investment in Workstream was announced by Todd Mavis, ... is a supplier of talent acquisition and talent ...
... 20, 2011 Cardinal Health today announced that this ... show for independent pharmacies, is the largest in the ... This year,s event, taking place July 20-23 ... hotel, features a 100,000-square-foot trade show floor, highlighting buying ...
Cached Medicine Technology:First Advantage Invests in Workstream Inc. 2First Advantage Invests in Workstream Inc. 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 2Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 3Nearly 7,000 Participate in Cardinal Health's Largest-Ever Annual Trade Show for Independent Pharmacies 4
(Date:6/19/2013)... Raton, FL (PRWEB) June 19, 2013 At ... about the positive changes and growth that has occurred over ... nationwide travel club. , Shuman said, "Travel Services has added ... to heights beyond belief. Membership is up, even in ... to meet the demands of members." , Having been in ...
(Date:6/19/2013)... neuron disease Amyotrophic lateral sclerosis (ALS), also known as ... which can be classified into four distinct stages, report ... University of Pennsylvania in the Annals of Neurology ... cord tissues shows, for the first time, how the ... in the central nervous system to other regions of ...
(Date:6/19/2013)... molecule derived from a naturally occurring compound (apocynin), ... mice with Parkinson,s Disease symptoms by preventing deficits ... in the May 28, 2013 edition of ... Ph.D., postdoctoral fellow at the Medical College of ... paper. Balaraman Kalyanaraman, Ph.D., Harry R. & ...
(Date:6/19/2013)... Imprivata ®, a leading global provider of ... OneSign ® leads the single sign-on (SSO) category in ... Services report . CIOs and other healthcare executives iwere ... of its products and the quality of its customer ... integral to their long-term healthcare IT strategy. , ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 The US Food ... a third ultra cohesive gel breast implant, Mentor Worldwide’s MemoryShape™. ... 410 in February 2013. The FDA announced the approval of ... approved for primary augmentations in women 22 years ... any age. , The FDA’s approval comes after six ...
Breaking Medicine News(10 mins):Health News:Former Owner Eric Shuman Endorses New Owners and Changes Made in Last Year Since Shuman Sold Travel Services Center at Member Conference 2Health News:Staging system in ALS shows potential tracks of disease progression, Penn study finds 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 2Health News:Imprivata Tops Single Sign-On Category in KLAS 2013 Mid-Term Performance Review 3Health News:FDA Approved Mentor® MemoryShape™ Breast Implants Now Offered to Patients at Swan Center for Plastic Surgery 2
... to the food chain via the Bernard Matthews plant, which ... in early February this year. , ,The Public ... turkey had to pass through the plant situated in Holton ... outbreak of the avian influenza and resumption of production services ...
... believe they may be on the right track ... key they say is stimulation of the occipital nerve. ... head and neck of the sufferers and giving them remotes ... reached separate research groups That included neurologists from the ...
... 8. According to statistics over one lac people Indians are ... cent die as they do not get timely treatment. ... Health Check-up package in connection with World Kidney Day-2007. The ... consultation and urine analysis for random glucose and creatinine. ...
... Want to de-stress, tone up your body or build your confidence? How ... and step on the dance floor// . ,'I tried going ... Then I started going for walks but I got bored of that ... stopped since,' said Suman Vohra, a doctor at the Apollo Hospital here. ...
... Implantable materials that grab stem cells and spur their ... and her colleagues// at MIT have created a new ... transplant environment--a key step in cell-transplant therapies. Scientists are ... well it can help heal fractures. ,"Creating ...
... schools and homes were housed under asbestos roofs. The children ... the repercussion of living their childhood days under asbestos roofs, ... cancer- Mesothelioma. Almost 5% of all lung cancers in the ... ,Mesothelioma is a medical term used to describe a cancer ...
Cached Medicine News:Health News:Doctors Put on Their Dancing Shoes to De-stress 2Health News:Healing Bone With Stem Cells 2
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: